Your browser doesn't support javascript.
loading
Seeking an optimal dosing regimen for OZ439/DSM265 combination therapy for treating uncomplicated falciparum malaria.
Dini, Saber; Zaloumis, Sophie G; Price, David J; Gobeau, Nathalie; Kümmel, Anne; Cherkaoui, Mohammed; Moehrle, Joerg J; McCarthy, James S; Simpson, Julie A.
Afiliación
  • Dini S; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia.
  • Zaloumis SG; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia.
  • Price DJ; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia.
  • Gobeau N; Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital, Melbourne, Australia.
  • Kümmel A; Medicines for Malaria Venture, Geneva, Switzerland.
  • Cherkaoui M; IntiQuan, Basel, Switzerland.
  • Moehrle JJ; Medicines for Malaria Venture, Geneva, Switzerland.
  • McCarthy JS; Medicines for Malaria Venture, Geneva, Switzerland.
  • Simpson JA; Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital, Melbourne, Australia.
J Antimicrob Chemother ; 76(9): 2325-2334, 2021 08 12.
Article en En | MEDLINE | ID: mdl-34179977
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pirimidinas / Triazoles / Malaria Falciparum / Malaria / Antimaláricos Tipo de estudio: Prognostic_studies Idioma: En Revista: J Antimicrob Chemother Año: 2021 Tipo del documento: Article País de afiliación: Australia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pirimidinas / Triazoles / Malaria Falciparum / Malaria / Antimaláricos Tipo de estudio: Prognostic_studies Idioma: En Revista: J Antimicrob Chemother Año: 2021 Tipo del documento: Article País de afiliación: Australia